Amphastar Pharmaceuticals Current Ratio 2012-2019 | AMPH

Amphastar Pharmaceuticals current ratio from 2012 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Amphastar Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.23B $0.11B 2.06
2018-12-31 $0.22B $0.11B 2.06
2018-09-30 $0.20B $0.10B 2.02
2018-06-30 $0.17B $0.09B 1.94
2018-03-31 $0.17B $0.07B 2.40
2017-12-31 $0.19B $0.07B 2.80
2017-09-30 $0.18B $0.06B 3.08
2017-06-30 $0.19B $0.06B 3.04
2017-03-31 $0.19B $0.07B 2.63
2016-12-31 $0.18B $0.06B 3.04
2016-09-30 $0.19B $0.06B 3.13
2016-06-30 $0.18B $0.07B 2.76
2016-03-31 $0.17B $0.07B 2.67
2015-12-31 $0.18B $0.06B 2.93
2015-09-30 $0.20B $0.07B 2.82
2015-06-30 $0.20B $0.07B 2.94
2015-03-31 $0.20B $0.07B 2.81
2014-12-31 $0.20B $0.06B 3.16
2014-09-30 $0.22B $0.06B 3.41
2014-06-30 $0.21B $0.06B 3.81
2014-03-31 $0.18B $0.07B 2.44
2013-12-31 $0.17B $0.07B 2.65
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.17B $0.06B 2.76
2012-09-30 $0.00B $0.00B 0.00
2012-06-30 $0.00B $0.00B 0.00
2012-03-31 $0.00B $0.00B 0.00
2011-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.933B $0.295B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $37.999B 6.92
Mylan (MYL) United Kingdom $8.773B 3.83
Teva Pharmaceutical Industries (TEVA) Israel $8.379B 3.28
Bausch Health Cos (BHC) Canada $7.555B 5.16
Dr Reddy's Laboratories (RDY) India $6.155B 23.02
Supernus Pharmaceuticals (SUPN) United States $1.645B 16.44
Voyager Therapeutics (VYGR) United States $0.893B 0.00
Homology Medicines (FIXX) United States $0.809B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.778B 1.16
Akorn (AKRX) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.431B 0.00
Assembly Biosciences (ASMB) United States $0.371B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.347B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.275B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.125B 0.00
Acasti Pharma (ACST) Canada $0.071B 0.00
Agile Therapeutics (AGRX) United States $0.058B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Teligent (TLGT) United States $0.030B 0.00
Evoke Pharma (EVOK) United States $0.015B 0.00
Aevi Genomic Medicine (GNMX) United States $0.011B 0.00